Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
37%
OVERLAP
BY WEIGHT
13
# OF OVERLAPPING
HOLDINGS
HART
69
HOLDINGS
21%
ALSO IN HRTS
HRTS
45
HOLDINGS
29%
ALSO IN HART
SECTOR DRIFT (HART minus HRTS)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in HART |
Weight in HRTS |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 7.5% | 10.9% | 7.5% |
|
UNITEDHEALTH GROUP INC | 6.7% | 5.1% | 5.1% |
|
JOHNSON & JOHNSON | 7.5% | 3.9% | 3.9% |
 |
NOVO NORDISK A/S-B | 3.2% | 4.8% | 3.2% |
|
ABBOTT LABORATORIES | 3.4% | 3.0% | 3.0% |
HART Overweight Relative to HRTS
|
APPLE INC | 7.5% |
|
ALPHABET INC. CLASS A | 5.8% |
|
PFIZER INC | 5.4% |
 |
NOVARTIS AG | 3.6% |
|
JOHNSON & JOHNSON | 3.6% |
 |
ASTRAZENECA PLC | 3.2% |
 |
SANOFI-AVENTIS | 3.2% |
|
ELEVANCE HEALTH INC | 2.9% |
|
HCA HOLDINGS INC | 2.2% |
|
NIKE INC -CL B | 1.8% |
HART Underweight Relative to HRTS
|
THERMO FISHER SCIENTIFIC INC | -5.0% |
|
MERCK & CO. INC. | -4.3% |
|
ROCHE HOLDINGS LTD-SPONS ADR | -3.8% |
|
REVOLUTION MEDICINES, INC. | -3.7% |
|
ELI LILLY & CO | -3.3% |
|
GILEAD SCIENCES INC | -3.2% |
|
BRIDGEBIO PHARMA, INC. | -3.1% |
|
VERTEX PHARMACEUTICALS INC | -3.0% |
|
DANAHER CORP | -2.9% |
|
ABBVIE INC | -2.3% |